首页 | 本学科首页   官方微博 | 高级检索  
     


Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight
Authors:Sarah D. McDonald  Eric PesarchukAndrew Don-Wauchope  Hala El Zimaity  Alison C. Holloway
Affiliation:
  • a Division of Maternal-Fetal Medicine, Departments of Obstetrics & Gynecology, Diagnostic Imaging, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
  • b Division of Reproductive Biology, Department of Obstetrics & Gynecology, McMaster University, Hamilton, Canada ON L8N 3Z5
  • c Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada ON L8N 3Z5
  • d Hamilton Regional Laboratory Medicine Program, Hamilton, Canada ON L8N 3Z5
  • e Laboratory Medicine Program, University Health Network/University of Toronto, Toronto, Canada ON L8N 3Z5
  • Abstract:Although a high-fat diet (HFD) is recognized as an important contributor to obesity, human research is limited by confounders such as income, whereas animal research has typically examined diet during specific developmental periods rather than throughout the lifespan. We hypothesized that the use of an HFD in short-term studies as has been commonly done in animals does not adequately reflect the lifelong dietary patterns seen frequently in humans with consequent metabolic disturbances. We examined the impact of HFD from weaning until 39 weeks (middle age) on the metabolism of male rats. At 7, 26, and 39 weeks, glucose tolerance tests were performed, a subset of animals was euthanized, and serum and tissues were collected. After 4 weeks, preceding increased body weight, HFD animals had increased intra-abdominal fat, triglycerides, and hyperglycemia. Hyperinsulinemia was insufficient to maintain normoglycemia, and beta cell mass and glucagon-like peptide 1 decreased over time in HFD and control animals. Despite lacking significant lipid abnormalities, nonalcoholic fatty liver disease was evident by 39 weeks. Our HFD model demonstrated that significant metabolic abnormalities may go undetected by current standard screening such as weighing and biochemistry.
    Keywords:AUC, area under the curve   ANOVA, analysis of variance   β-cell, beta cell   C, control   CVD, cardiovascular disease   DIO, diet-induced obesity   FFA, free fatty acid   GLP-1, glucagon-like peptide 1   GTT, glucose tolerance test   HFD, high-fat diet   HDL, high-density lipoprotein   HSI, hepatosomatic index   IGT, impaired glucose tolerance   LDL, low-density lipoprotein   NAFLD, nonalcoholic fatty liver disease   TG, triglycerides   T2DM, type 2 diabetes mellitus
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号